Loading patent…
AssigneeProgena Inc.
InventorsAlexander Feskov, Irina Feskova, Ievgeniia Zhylkova, Stanislav Zhilkov
Estimating the term…
A method of in vitro fertilization wherein the embryo is implanted into the uterus of a female patient at least two, and preferably three to twelve months after the eggs are retrieved from the patient in order to reduce the effect of autoimmune rejection of the embryo by the patient's autoimmune system and increase the probability and success of pregnancy and wherein prior to embryo implantation, the endometrium in the uterus is prepared for embryo implantation by introducing peripheral blood mononuclear cells (PBMCs) into the uterus. The procedure is combined with cryopreservation techniques to preserve the oocytes or the IVF-produced embryos of the patient.
A method of producing a peripheral blood mononuclear cell (“PBMC”) composition suitable for repairing or engineering a tissue comprising:
Dependencies are inferred from the claim text.